Wang Yinan, Zhao Min, Xin Yi, Liu Jiajia, Wang Miao, Zhao Chunjie
School of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, China.
School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, China.
J Ethnopharmacol. 2016 Jun 5;185:272-81. doi: 10.1016/j.jep.2016.03.043. Epub 2016 Mar 18.
Cortex Fraxini (CF) is an important traditional Chinese herbal medicine used for the treatment of gout and hyperuricemia.
The aim of this study was to evaluate the anti-hyperuricemic effect of CF on hyperuricemic rats and to investigate its mechanism of action.
Metabolomics based on NMR and MS was used to study the therapeutic effect of CF on hyperuricemic rats. Plasma determination of uric acid (UA) showed that CF treatment markedly improved the UA level. Subsequently, metabolomics analysis was conducted using samples of plasma, kidney and urine, and orthogonal partial least squares-discriminant analysis (OPLS-DA) combined with principal component analysis (PCA) were used to detect potential biomarkers.
A total of 26 biomarkers were identified as being primarily involved in amino acid metabolism, lipid metabolism, purine metabolism, amino acid metabolism and carbohydrate metabolism, and hyperuricemia can disturb the balance of many of these metabolic pathways in vivo.
The variations in biomarkers revealed the therapeutic mechanism of CF, and a number of these biomarkers are not only significant for early diagnosis but also for predicting hyperuricemia.
秦皮是一种用于治疗痛风和高尿酸血症的重要传统中草药。
本研究旨在评估秦皮对高尿酸血症大鼠的抗高尿酸血症作用,并探讨其作用机制。
基于核磁共振(NMR)和质谱(MS)的代谢组学用于研究秦皮对高尿酸血症大鼠的治疗效果。血浆尿酸(UA)测定表明,秦皮治疗显著改善了UA水平。随后,使用血浆、肾脏和尿液样本进行代谢组学分析,并采用正交偏最小二乘判别分析(OPLS-DA)结合主成分分析(PCA)来检测潜在生物标志物。
共鉴定出26种生物标志物,主要涉及氨基酸代谢、脂质代谢、嘌呤代谢、氨基酸代谢和碳水化合物代谢,高尿酸血症可扰乱体内许多这些代谢途径的平衡。
生物标志物的变化揭示了秦皮的治疗机制,其中一些生物标志物不仅对早期诊断有意义,而且对预测高尿酸血症也有意义。